Tumor necrosis factor-? inhibitors in therapy for psoriatic arthritis
The paper presents the data available in the literature on the efficacy and tolerability of basic tumor necrosis factor α inhibitors (TNF α) etanercept, adalimumab, infliximab in the treatment of psoriatic arthritis (PsA) and their effects on the major manifestations of this disease - cutaneous and...
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artikkeli |
| Kieli: | Russian |
| Julkaistu: |
IMA-PRESS LLC
2010-12-01
|
| Sarja: | Современная ревматология |
| Aiheet: | |
| Linkit: | https://mrj.ima-press.net/mrj/article/view/326 |
| _version_ | 1826557001226780672 |
|---|---|
| author | Vladimir Vasilyevich Badokin I A Troshkina Yu L Korsakova |
| author_facet | Vladimir Vasilyevich Badokin I A Troshkina Yu L Korsakova |
| author_sort | Vladimir Vasilyevich Badokin |
| collection | DOAJ |
| description | The paper presents the data available in the literature on the efficacy and tolerability of basic tumor necrosis factor α inhibitors (TNF α) etanercept, adalimumab, infliximab in the treatment of psoriatic arthritis (PsA) and their effects on the major manifestations of this disease - cutaneous and articular syndromes. It generalizes the authors experience in treating PA with infliximab. The value of TNF α inhibitors in the complex therapy of PsA and indications for their use in this disease are analyzed |
| first_indexed | 2024-04-10T02:09:11Z |
| format | Article |
| id | doaj.art-f79b45641ce4429a8a0729a6bf7f7fda |
| institution | Directory Open Access Journal |
| issn | 1996-7012 2310-158X |
| language | Russian |
| last_indexed | 2025-03-14T08:21:39Z |
| publishDate | 2010-12-01 |
| publisher | IMA-PRESS LLC |
| record_format | Article |
| series | Современная ревматология |
| spelling | doaj.art-f79b45641ce4429a8a0729a6bf7f7fda2025-03-02T13:10:54ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2010-12-0144727610.14412/1996-7012-2010-6411631Tumor necrosis factor-? inhibitors in therapy for psoriatic arthritisVladimir Vasilyevich BadokinI A TroshkinaYu L KorsakovaThe paper presents the data available in the literature on the efficacy and tolerability of basic tumor necrosis factor α inhibitors (TNF α) etanercept, adalimumab, infliximab in the treatment of psoriatic arthritis (PsA) and their effects on the major manifestations of this disease - cutaneous and articular syndromes. It generalizes the authors experience in treating PA with infliximab. The value of TNF α inhibitors in the complex therapy of PsA and indications for their use in this disease are analyzedhttps://mrj.ima-press.net/mrj/article/view/326tumor necrosis factor-α inhibitorspsoriatic arthritis |
| spellingShingle | Vladimir Vasilyevich Badokin I A Troshkina Yu L Korsakova Tumor necrosis factor-? inhibitors in therapy for psoriatic arthritis Современная ревматология tumor necrosis factor-α inhibitors psoriatic arthritis |
| title | Tumor necrosis factor-? inhibitors in therapy for psoriatic arthritis |
| title_full | Tumor necrosis factor-? inhibitors in therapy for psoriatic arthritis |
| title_fullStr | Tumor necrosis factor-? inhibitors in therapy for psoriatic arthritis |
| title_full_unstemmed | Tumor necrosis factor-? inhibitors in therapy for psoriatic arthritis |
| title_short | Tumor necrosis factor-? inhibitors in therapy for psoriatic arthritis |
| title_sort | tumor necrosis factor inhibitors in therapy for psoriatic arthritis |
| topic | tumor necrosis factor-α inhibitors psoriatic arthritis |
| url | https://mrj.ima-press.net/mrj/article/view/326 |
| work_keys_str_mv | AT vladimirvasilyevichbadokin tumornecrosisfactorinhibitorsintherapyforpsoriaticarthritis AT iatroshkina tumornecrosisfactorinhibitorsintherapyforpsoriaticarthritis AT yulkorsakova tumornecrosisfactorinhibitorsintherapyforpsoriaticarthritis |